Zacharias Amy J
Public Communications Contact at Healthcare Royalty Management LLC
Network origin in Zacharias Amy J first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut.
27
| Subsidiary | Investment Managers | 27 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Zacharias Amy J via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| CAMBREX CORPORATION | Pharmaceuticals: Generic | Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Sales & Marketing | |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Executive Officer Chief Investment Officer | |
Apax Partners, Inc.
 Apax Partners, Inc. Investment ManagersFinance Founded in 1976, Apax Partners, Inc. is a venture capital/private equity firm located in New York City. The firm is a subsidiary of London-based Apax Partners LLP | Investment Managers | Corporate Officer/Principal | |
NXXI, Inc.
 NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Pharmaceuticals: Major | Director/Board Member | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
AcuFocus, Inc.
 AcuFocus, Inc. Medical SpecialtiesHealth Technology AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INVUITY INC | Medical Distributors | Chairman | |
| AQUESTIVE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
PharmacoPhotonics, Inc.
 PharmacoPhotonics, Inc. Electronic Equipment/InstrumentsElectronic Technology PharmacoPhotonics, Inc. is a medical technology company. Its technology measures blood volume and kidney function and it impacts heart failure, cardio-renal, major surgery, sepsis, critical care, and kidney disease patients. The company was founded in 2006 and is headquartered in Indianapolis, IN. | Electronic Equipment/Instruments | Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Adams Harkness & Hill Investment Banking
 Adams Harkness & Hill Investment Banking Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Adams Harkness & Hill Investment Banking is a company based in Boston, MA. | Investment Managers | Corporate Officer/Principal | |
Vector Securities LLC
 Vector Securities LLC Investment Banks/BrokersFinance Part of Prudential Financial, Inc., Vector Securities LLC is a company that provides investment banking services. The company is based in Deerfield, IL. Vector Securities was acquired by Prudential Securities on June 09, 1999. | Investment Banks/Brokers | Corporate Officer/Principal | |
| SUNY Upstate Medical University | College/University | Doctorate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Director/Board Member Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
| FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Director/Board Member | |
Helomics Corp.
 Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | Medical/Nursing Services | Director/Board Member Director/Board Member Chairman | |
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Pharmaceuticals: Major | Chief Executive Officer | |
| Kenan-Flagler Business School | College/University | Masters Business Admin Masters Business Admin | |
Suneva Medical, Inc.
 Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Suneva Medical, Inc. develops, manufactures and commercializes novel, differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. It offers ArteFill, ReFissa, Bellafill, and ReGenica Skincare products. The company is headquartered in San Diego, CA. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member Chairman Director/Board Member | |
NovaQuest Capital Management LLC
 NovaQuest Capital Management LLC Investment ManagersFinance NovaQuest Capital Management LLC (NovaQuest Capital Management) is a private equity firm founded in 2010 by John Layton Bradley and Jonathan Edward Tunnicliffe. The firm is headquartered in Raleigh, North Carolina. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Harvard Business School Health Industry Alumni Association | Director/Board Member | ||
| The University of North Carolina at Greensboro | College/University | Undergraduate Degree Undergraduate Degree | |
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Chairman | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| University of Virginia School of Law | College/University | Graduate Degree | |
Paul Capital Partners (United Kingdom)
 Paul Capital Partners (United Kingdom) Investment ManagersFinance Part of Paul Capital Partners LP, Paul Capital Partners (United Kingdom) is a British company that provides investment consulting services. The company is based in London, UK. | Investment Managers | Private Equity Investor | |
Palvella Therapeutics, Inc.
 Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | Biotechnology | Director/Board Member | |
| VAXART, INC. | Biotechnology | Chairman | |
Royaltyrx Capital LLC
 Royaltyrx Capital LLC Financial ConglomeratesFinance Royaltyrx Capital LLC provides investment services in the pharmaceutical industry. The American company was founded by Todd C. Davis. | Financial Conglomerates | Founder | |
Benuvia Therapeutics, Inc.
 Benuvia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Benuvia Therapeutics, Inc. engages in pharmaceutical and therapeutic drug development services. The company is headquartered in Chandler, AZ. | Pharmaceuticals: Major | Chief Executive Officer | |
Healthcare Royalty, Inc.
 Healthcare Royalty, Inc. Financial ConglomeratesFinance Healthcare Royalty, Inc operates as a royalty acquisition company. It focuses on growth assets and emerging companies driving innovation in the biopharmaceutical industry. The company is headquartered Stamford, CT. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Virocell Biologics Ltd.
 Virocell Biologics Ltd. BiotechnologyHealth Technology Virocell Biologics Ltd. is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials. The company is based in London, UK. The British company leverages its expertise in vector manufacture directly into the production of gene-modified cells, both adherent cells such as Mesenchymal Stromal/Stem cells and suspension cultures such as CAR T-cells. Virocell Biologics is committed to leveraging its deep experience to rapidly design and select a manufacturing strategy best suited to the client's objectives. The company was founded by Farzin Farzaneh, John W. Hadden. John W. Hadden has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| CHROMOCELL THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Chairman |
Statistics
International
| United States | 47 |
| United Kingdom | 3 |
| Finland | 2 |
| Luxembourg | 2 |
Sectoral
| Health Technology | 21 |
| Finance | 14 |
| Consumer Services | 12 |
| Electronic Technology | 3 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 191 |
| Independent Dir/Board Member | 52 |
| Corporate Officer/Principal | 52 |
| Founder | 46 |
| Chairman | 28 |
Most connected contacts
| Insiders | |
|---|---|
| Robert Langer | 88 |
| William Burns | 27 |
| Julie McHugh | 26 |
| Marc Kozin | 24 |
| Todd Davis | 23 |
| Gregory Brown | 22 |
| Warren Cooper | 21 |
| Gary Lyons | 20 |
| Mardi Dier | 18 |
| Clarke Futch | 16 |
| Nat Ricciardi | 14 |
| Paul J. Hadden | 9 |
| Thomas K. Conner | 7 |
| Matt Bullard | 7 |
| House Joshua | 7 |
- Stock Market
- Insiders
- Zacharias Amy J
- Company connections
